17th Annual Optimising Clinical Trials Summit: Site Selection, Feasibility and Patient Recruitment
Event is Over
Stay Updated for 2024 edition
Past Speakers
SEE THE PREVIOUS SPEAKERS & CASE STUDIES
CASE STUDY
Modern Approaches in Clinical Research – Planning as The Path To Success
New approaches are introduced in pharmaceutical research at a glacial speed. The presentation highlights such approaches as DCT, use of RWD for evidence generation. It highlights the status, hurdles to implementation and gives practical guidance for implementation.
- 01DCT
- 02Modern planning
CASE STUDY
The Advantage of AI, Blockchain, Cloud, And Digitisation In The Clinical Trials Industry
Traditional clinical trials (CT) require a very large number of patients to demonstrate regulatory agencies sufficient efficacy. New models of clinical trials are needed due to the limited number of patients and costs. External Control Arms offers us the opportunity to carry out external controlled trials. New technologies like blockchain and AI are the new tools to change the paradigm in clinical development and clinical trials, how can we implement a control arm with AI and what is the new role of the blockchain-implemented CRFs?
- 01AI and ML
- 02Artificial Control
- 03Arms Blockchain
- 04Smart Contracts
CASE STUDY
Impact Of Russian – Ukrainian War on The World of Clinical Research & Patient Retention
In the past decades, a growing number of patients in Clinical Trials came from Ukraine and Russia. With the war ongoing in Ukraine, and the sanctions in place against Russia, this has come to an abrupt stop. New patients need to be recruited from other countries, and existing patients in Ukraine need to be managed using contingency measures. What kind of contingency measures are available? And what kind of actions are recommended by health authorities?
- 01What is the impact of Russian – Ukrainian war on Clinical Trials in Russia and Ukraine?
- 02What do regulatory agencies recommend to do?
- 03How to be prepared for the unexpected in your current and future protocols?
CASE STUDY
Inclusion of PROs in Clinical Trials
In neurological disorders not only clinical and imaging data are of importance. The inclusion of cognitive and social elements such as education, nutrition and work/activities need to be considered. The inclusion of PROs in clinical trials contributes to long-term access and other social factors. Correlation of the cognitive data and PRO data with clinical data to validate the long-term outcomes.
- 01Are Supply Chain planning process processes still relevant?
- 02How should Supply Chain Strategy be a key pillar in any business Strategy?
- 03Supply Chain evolution to adopt Sustainability agendas
CASE STUDY
Incorporation of Patients Insights in Feasibility
Patients are the main Clinical Trials actors, and their role goes beyond participation in the study. Their opinions are very valuable to ensure that Clinical Trials Design can provide answers to real patients’ needs and that the study burden does not limit the participation.
Early and active collaboration with patients is the most effective way to incorporate their insights across the R&D process.
- 01Patients’ role in clinical trials goes far beyond their participation in the study
- 02Incorporation of patients’ insights improves the quality of the study design and reduces the study burden
- 03Establishing early collaboration with Patient Partners is required to develop long-term and effective collaborations
CASE STUDY
Modern Approaches in Clinical Research – Planning as The Path To Success
New approaches are introduced in pharmaceutical research at a glacial speed. The presentation highlights such approaches as DCT, use of RWD for evidence generation. It highlights the status, hurdles to implementation and gives practical guidance for implementation.
- 01DCT
- 02Modern planning
CASE STUDY
The Advantage of AI, Blockchain, Cloud, And Digitisation In The Clinical Trials Industry
Traditional clinical trials (CT) require a very large number of patients to demonstrate regulatory agencies sufficient efficacy. New models of clinical trials are needed due to the limited number of patients and costs. External Control Arms offers us the opportunity to carry out external controlled trials. New technologies like blockchain and AI are the new tools to change the paradigm in clinical development and clinical trials, how can we implement a control arm with AI and what is the new role of the blockchain-implemented CRFs?
- 01AI and ML
- 02Artificial Control
- 03Arms Blockchain
- 04Smart Contracts
CASE STUDY
Impact Of Russian – Ukrainian War on The World of Clinical Research & Patient Retention
In the past decades, a growing number of patients in Clinical Trials came from Ukraine and Russia. With the war ongoing in Ukraine, and the sanctions in place against Russia, this has come to an abrupt stop. New patients need to be recruited from other countries, and existing patients in Ukraine need to be managed using contingency measures. What kind of contingency measures are available? And what kind of actions are recommended by health authorities?
- 01What is the impact of Russian – Ukrainian war on Clinical Trials in Russia and Ukraine?
- 02What do regulatory agencies recommend to do?
- 03How to be prepared for the unexpected in your current and future protocols?
CASE STUDY
Inclusion of PROs in Clinical Trials
In neurological disorders not only clinical and imaging data are of importance. The inclusion of cognitive and social elements such as education, nutrition and work/activities need to be considered. The inclusion of PROs in clinical trials contributes to long-term access and other social factors. Correlation of the cognitive data and PRO data with clinical data to validate the long-term outcomes.
- 01Are Supply Chain planning process processes still relevant?
- 02How should Supply Chain Strategy be a key pillar in any business Strategy?
- 03Supply Chain evolution to adopt Sustainability agendas
Hottest topics
LOOK AT THE TOPICS THAT WERE DISCUSSED
- 01Advancing patient-centred trials: How to leverage innovations and technologies?
- 02Unlock the power of the clinical data: Shaping the future of clinical trials
- 03Designing randomised controlled trials: Best practices and innovations
- 04Expanding the pool of engaged patients: Optimisation of patient recruitment
- 05The roles and responsibilities of stakeholders in the sharing of clinical trial information
- 06Regulations on clinical trials: The influence that will shape medical affairs
Testimonials
What our users say about our conferences
Sponsors
Our Trusted Sponsor at This Summit
Download our App to
Enhance Your Event Experience
This innovative app is aimed at enhancing your networking experience through a seamless blend of interaction and connectivity. We have carefully crafted this application with new features that empower you to make the most out of your engagements, ensuring personalised experiences and seamless networking opportunities.
STAY UPDATED FOR THE 2024 EDITION
With All the Updates Regarding the Upcoming Edition of This Event.